Related Experiment Videos

Identification of tuberous sclerosis 2 messenger RNA splice variants that are conserved and differentially expressed

G H Xiao1, F Jin, R S Yeung

  • 1Division of Medical Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.

Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|September 1, 1995
PubMed

Insights

The Tuberous sclerosis 2 (Tsc2) gene in Eker rats, a model for inherited cancer, exhibits alternative splicing. This generates multiple Tsc2 isoforms with potential roles in cell regulation and development.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • The Tuberous sclerosis 2 (Tsc2) gene is implicated in inherited cancer susceptibility, as demonstrated by germline insertion in the Eker rat model.
  • Mutations in this tumor suppressor gene lead to various neoplasms in rats and hamartomas in humans.

Purpose of the Study:

  • To characterize the rat Tsc2 cDNA and identify alternative splicing variants.
  • To investigate the homology between rat and human Tsc2 genes and their functional implications.

Main Methods:

  • Sequence analysis of rat Tsc2 cDNA clones from a kidney library.
  • Identification and characterization of alternatively spliced transcripts and their encoded protein domains.

Main Results:

  • Rat Tsc2 cDNA is highly homologous to human Tsc2, including a conserved rap1GAP catalytic domain.
  • Alternative splicing of Tsc2 transcripts results in isoforms with variations in exon inclusion/exclusion and cryptic splice site usage.
  • A minimum of four and potentially eight differentially expressed Tsc2 isoforms were identified in a tissue-specific manner.

Conclusions:

  • The identified Tsc2 splice variants are conserved in humans, suggesting a significant functional role.
  • These Tsc2 isoforms likely play roles in diverse cell regulatory and developmental processes.

Related Concept Videos